2014: Cardiometabolic Side Effects of Risperidone in Children with Autism
This course will provide an overview of lipocentric cardiometabolic side effects of risperidone in children diagnosed with autism in a recent clinical trial. An interactive discussion of lipocentric pathophysiologic changes related to obesity, insulin resistance and fatty liver disease will include associated office-based screening measures. In conclusion a preliminary pediatric screening schedule to monitor risperidone treatment in the office.
Speaker: Susan Boorin, PhD(c), MSN, PMHNP-BC
Disclosures: The speaker has no conflict of interest, commercial support, or off-label use to disclose. The activity planners have no conflicts of interest to disclose.
Session Length: 45 minutes
Target Audience: APRN
Upon completion of this presentation, the participant will be able to:
1. Describe four cardiometabolic changes associated with risperidone treatment in children diagnosed with autism based on a recent clinical trial.
2. Describe office based clinical and laboratory tests to screen for lipocentric pathophysiologic changes associated risperidone treatment focusing on obesity, insulin resistance and fatty liver disease.
3. Describe pediatric specific considerations when monitoring children treated with risperidone based on age/gender, current guidelines and preliminary recommendations from a recent clinical trial.
Key words: obesity, weight gain, BMI, pharmacology, child & adolescent, autism
Continuing Nursing Education
0.75 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.
The content of this CNE activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Thursday, October 20, 2011: 9:15am – 10:00am
Child & Adolescent Track
APNA 25th Annual Conference
Release Date: January 25, 2012
The contact hours for this session expire: March 14, 2014